| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS10052702 | HBV | ENSG00000168830.8 | protein_coding | HTR1E | No | No | 3354 | P28566 |
| TVIS30087304 | HIV | ENSG00000168830.8 | protein_coding | HTR1E | No | No | 3354 | P28566 |
| TVIS20038134 | HPV | ENSG00000168830.8 | protein_coding | HTR1E | No | No | 3354 | P28566 |
| TVIS20038135 | HPV | ENSG00000168830.8 | protein_coding | HTR1E | No | No | 3354 | P28566 |
| TVIS20045646 | HPV | ENSG00000168830.8 | protein_coding | HTR1E | No | No | 3354 | P28566 |
| TVIS20026950 | HPV | ENSG00000168830.8 | protein_coding | HTR1E | No | No | 3354 | P28566 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | HTR1E |
|---|---|
| DrugBank ID | DB00315 |
| Drug Name | Zolmitriptan |
| Target ID | BE0000476 |
| UniProt ID | P28566 |
| Regulation Type | agonist |
| PubMed IDs | 29352859; 9399012 |
| Citations | Rubio-Beltran E, Labastida-Ramirez A, Villalon CM, MaassenVanDenBrink A: Is selective 5-HT1F receptor agonism an entity apart from that of the triptans in antimigraine therapy? Pharmacol Ther. 2018 Jun;186:88-97. doi: 10.1016/j.pharmthera.2018.01.005. Epub 2018 Jan 17.@@Martin GR: Pre-clinical pharmacology of zolmitriptan (Zomig; formerly 311C90), a centrally and peripherally acting 5HT1B/1D agonist for migraine. Cephalalgia. 1997 Oct;17 Suppl 18:4-14. |
| Groups | Approved; Investigational |
| Direct Classification | Tryptamines and derivatives |
| SMILES | CN(C)CCC1=CNC2=CC=C(C[C@H]3COC(=O)N3)C=C12 |
| Pathways | |
| PharmGKB | PA451975 |
| ChEMBL | CHEMBL1185 |
